Using a comprehensive set of state-of-the-art RNA tools and technologies, we’re creating therapies with the precision, control, and flexibility needed to address the underlying biology and unique complexities of each disease.
We are advancing a diverse portfolio of RNA medicines designed to reprogram the immune system — and ultimately, to offer simpler, safer, and more accessible alternatives to today’s complex treatments.
Our culture is rooted in purpose and powered by collaboration. We thrive on scientific excellence, cross-functional teamwork, and the shared commitment to make a meaningful difference for patients.
This links to an external website.